The abnormal activation of STAT3 has been shown to be closely related to chemotherapy resistance in bladder cancer [36], blood cancer [37], glioma [38], ovarian cancer [39], breast cancer [40] and acute myeloid leukemia [41]. This evidence concerns the gene STAT3 and central nervous system cancer.